UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope

Journal of Virology, 2005-09, Vol.79 (17), p.11214-11224

2005

Volltextzugriff (PDF)

Consistent Patterns of Change during the Divergence of Human Immunodeficiency Virus Type 1 Envelope from That of the Inoculated Virus in Simian/Human Immunodeficiency Virus-Infected Macaques

Journal of Virology, 2006-01, Vol.80 (2), p.999-1014

2006

Volltextzugriff (PDF)

Multigene DNA Priming-Boosting Vaccines Protect Macaques from Acute CD4+-T-Cell Depletion after Simian-Human Immunodeficiency Virus SHIV89.6P Mucosal Challenge

Journal of Virology, 2003-11, Vol.77 (21), p.11563-11577

2003

Volltextzugriff (PDF)

Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival

Journal of Virology, 1997-01, Vol.71 (1), p.284-290

1997

Volltextzugriff (PDF)

P05-10. Sequential immunization with a subtype B HIV-1 envelope quasispecies elicits broader neutralization than vaccination with a single envelope clone

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P86-P86, Article P86

2009

Volltextzugriff (PDF)

Transfer of Neutralizing IgG to Macaques 6 h but Not 24 h after SHIV Infection Confers Sterilizing Protection: Implications for HIV-1 Vaccine Development

Proceedings of the National Academy of Sciences - PNAS, 2003-12, Vol.100 (25), p.15131-15136

2003

Volltextzugriff (PDF)

Passive Immunotherapy in Simian Immunodeficiency Virus-Infected Macaques Accelerates the Development of Neutralizing Antibodies

Journal of Virology, 2004-06, Vol.78 (11), p.5983-5995

2004

Volltextzugriff (PDF)

V3 Variability can Influence the Ability of an Antibody to Neutralize or Enhance Infection by Diverse Strains of Human Immunodeficiency Virus Type 1

Proceedings of the National Academy of Sciences - PNAS, 1993-12, Vol.90 (24), p.11518-11522

1993

Volltextzugriff (PDF)

Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques

AIDS research and human retroviruses, 1997-11, Vol.13 (16), p.1375-1381

1997

Volltextzugriff (PDF)

Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection

Journal of Virology, 1993-01, Vol.67 (1), p.577-583

1993

Volltextzugriff (PDF)

Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons

Journal of Virology, 1992-01, Vol.66 (1), p.172-182

1992

Volltextzugriff (PDF)

N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes

The Journal of immunology (1950), 1991-11, Vol.147 (9), p.3128

1991

Volltextzugriff (PDF)

Inactivated Whole-Virus Vaccine Derived from a Proviral DNA Clone of Simian Immunodeficiency Virus Induces High Levels of Neutralizing Antibodies and Confers Protection Against Heterologous Challenge

Proceedings of the National Academy of Sciences - PNAS, 1992-03, Vol.89 (6), p.2175-2179

1992

Volltextzugriff (PDF)

Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120

The Journal of clinical investigation, 1992-06, Vol.89 (6), p.1952-1957

1992

Volltextzugriff (PDF)

Characterization of a CD4-Expressing Macaque Cell Line That Can Detect Virus after a Single Replication Cycle and Can Be Infected by Diverse Simian Immunodeficiency Virus Isolates

Virology (New York, N.Y.), 1995-11, Vol.213 (2), p.386-394

1995

Volltextzugriff (PDF)

Priming of CD4+T Cells Specific for Conserved Regions of Human Immunodeficiency Virus Glycoprotein gp120 in Humans Immunized with a Recombinant Envelope Protein

Proceedings of the National Academy of Sciences - PNAS, 1990-08, Vol.87 (16), p.6136-6140

1990

Volltextzugriff (PDF)

Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells

Nucleic acids research, 1991-07, Vol.19 (14), p.3979-3986

1991

Volltextzugriff (PDF)

Humoral immunity to HIV, SIV, and SHIV

AIDS (London), 1998, Vol.12 Suppl A, p.S121-S132

1998

Volltextzugriff (PDF)

Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques

AIDS research and human retroviruses, 1994-10, Vol.10 (10), p.1295-1304

1994

Volltextzugriff (PDF)

Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120

Science (American Association for the Advancement of Science), 1991-10, Vol.254 (5028), p.105-108

1991

Volltextzugriff (PDF)

Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor

The Journal of immunology (1950), 2021-03, Vol.206 (5), p.999-1012

2021

Volltextzugriff (PDF)

Biodistribution of neutralizing monoclonal antibodies IgG1 b12 and LALA in mucosal and lymphatic tissues of rhesus macaques

Retrovirology, 2012-09, Vol.9 (S2), p.P204-P204, Article P204

2012

Volltextzugriff (PDF)

Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with Simian immunodeficiency virus

AIDS research and human retroviruses, 1994-02, Vol.10 (2), p.195-204

1994

Volltextzugriff (PDF)

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

Immunology letters, 1996-06, Vol.51 (1), p.107-114

1996

Volltextzugriff (PDF)

Molecular Profile of an Antibody Response to HIV-1 as Probed by Combinatorial Libraries

Journal of molecular biology, 1993-04, Vol.230 (3), p.812-823

1993

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(93)
Tagungsberichte
(1)

Sprache

Englisch
(94)
Japanisch
(12)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope

Consistent Patterns of Change during the Divergence of Human Immunodeficiency Virus Type 1 Envelope from That of the Inoculated Virus in Simian/Human Immunodeficiency Virus-Infected Macaques

Multigene DNA Priming-Boosting Vaccines Protect Macaques from Acute CD4+-T-Cell Depletion after Simian-Human Immunodeficiency Virus SHIV89.6P Mucosal Challenge

Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival

P05-10. Sequential immunization with a subtype B HIV-1 envelope quasispecies elicits broader neutralization than vaccination with a single envelope clone

Transfer of Neutralizing IgG to Macaques 6 h but Not 24 h after SHIV Infection Confers Sterilizing Protection: Implications for HIV-1 Vaccine Development

Passive Immunotherapy in Simian Immunodeficiency Virus-Infected Macaques Accelerates the Development of Neutralizing Antibodies

V3 Variability can Influence the Ability of an Antibody to Neutralize or Enhance Infection by Diverse Strains of Human Immunodeficiency Virus Type 1

Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques

Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection

Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons

N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes

Inactivated Whole-Virus Vaccine Derived from a Proviral DNA Clone of Simian Immunodeficiency Virus Induces High Levels of Neutralizing Antibodies and Confers Protection Against Heterologous Challenge

Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120

Characterization of a CD4-Expressing Macaque Cell Line That Can Detect Virus after a Single Replication Cycle and Can Be Infected by Diverse Simian Immunodeficiency Virus Isolates

Priming of CD4+T Cells Specific for Conserved Regions of Human Immunodeficiency Virus Glycoprotein gp120 in Humans Immunized with a Recombinant Envelope Protein

Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells

Humoral immunity to HIV, SIV, and SHIV

Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques

Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120

Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor

Biodistribution of neutralizing monoclonal antibodies IgG1 b12 and LALA in mucosal and lymphatic tissues of rhesus macaques

Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with Simian immunodeficiency virus

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

Molecular Profile of an Antibody Response to HIV-1 as Probed by Combinatorial Libraries

Suchergebnisse filtern